James M. Mock
Chief Financial Officer
Common Stock
- Value context
- Unavailable
- Reported price
- Price not reported
Moderna, Inc.
Last 30 daysNo qualifying insider buying. Sales: $16.38M by 2 insiders.
Showing the first 6 of 20 trades on this page.
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Chief Financial Officer
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
President
Common Stock
President
Common Stock
President
Common Stock
President
Common Stock
President
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
President
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Financial Officer
Common Stock
Chief Financial Officer
Common Stock
Chief Financial Officer
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Legal Officer
Common Stock
Chief Legal Officer
Common Stock
Chief Legal Officer
Restricted Stock Units
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Legal Officer
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Financial Officer | Common StockOption exercise or conversion | 1,454Price not reported | Unavailable | Oct 5Filed Oct 7 · 2d later | SEC filing |
| Chief Financial Officer | Common StockExercise-price or tax withholding | 704$190.01 / share | $133.77K | Oct 5Filed Oct 7 · 2d later | SEC filing |
| Chief Financial Officer | Restricted Stock UnitsOption exercise or conversion | Derivative units1,454Exercise / conversion price not reported | Not a separate purchase | Oct 5Filed Oct 7 · 2d later | SEC filing |
| President | Common StockOption exercise or conversion10b5-1 | 76,453$12.21 / share | $933.49K | Sep 14Filed Sep 16 · 2d later | SEC filing |
| President | Common StockSale10b5-1 | 40,294$144.13 / share | $5.81M | Sep 14Filed Sep 16 · 2d later | SEC filing |
| President | Common StockOption exercise or conversion10b5-1 | 76,452$12.21 / share | $933.48K | Sep 15Filed Sep 16 · 1d later | SEC filing |
| President | Common StockSale10b5-1 | 40,281$146.07 / share | $5.88M | Sep 15Filed Sep 16 · 1d later | SEC filing |
| President | Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units76,453$12.21 exercise / conversion price | Not a separate purchase | Sep 14Filed Sep 16 · 2d later | SEC filing |
| President | Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units76,452$12.21 exercise / conversion price | Not a separate purchase | Sep 15Filed Sep 16 · 1d later | SEC filing |
| Chief Financial Officer | Common StockOption exercise or conversion10b5-1 | 19,836$30.96 / share | $614.12K | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Chief Financial Officer | Common StockSale10b5-12 trades | 34,836avg $134.49 / share | $4.69M | Sep 10Filed Sep 14 · 4d later | 2 filings
|
| Chief Financial Officer | Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units19,836$30.96 exercise / conversion price | Not a separate purchase | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Chief Financial Officer | Common StockOption exercise or conversion | 11,797Price not reported | Unavailable | Sep 4Filed Sep 8 · 4d later | SEC filing |
| Chief Financial Officer | Common StockExercise-price or tax withholding | 5,704$148.87 / share | $849.15K | Sep 4Filed Sep 8 · 4d later | SEC filing |
| Chief Financial Officer | Restricted Stock UnitsOption exercise or conversion | Derivative units11,797Exercise / conversion price not reported | Not a separate purchase | Sep 4Filed Sep 8 · 4d later | SEC filing |
| Chief Legal Officer | Common StockOption exercise or conversion | 11,797Price not reported | Unavailable | Sep 4Filed Sep 8 · 4d later | SEC filing |
| Chief Legal Officer | Common StockExercise-price or tax withholding | 5,704$148.87 / share | $849.15K | Sep 4Filed Sep 8 · 4d later | SEC filing |
| Chief Legal Officer | Restricted Stock UnitsOption exercise or conversion | Derivative units11,797Exercise / conversion price not reported | Not a separate purchase | Sep 4Filed Sep 8 · 4d later | SEC filing |
| Chief Legal Officer | Common StockOption exercise or conversion10b5-1 | 3,471$30.96 / share | $107.46K | Sep 1Filed Sep 3 · 2d later | SEC filing |
Showing the latest 20 of 147 trades. Show all 147 trades
Moderna, Inc. - Common Stock (MRNA) · Stock
The filing reports a purchase for the member.
Maria Elvira SalazarReporting House memberModerna, Inc. - Common Stock (MRNA) · Stock
The filing reports a partial sale for the member.
Maria Elvira SalazarReporting House member